TP-0591816

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameTP-0591816
Drug Alias NameTP-0591816
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionViral fusion proteins inhibitors
TargetsViral fusion proteins
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaisho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaisho Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A